Decipher Biosciences provide genomic testing for urological cancers

Reimagine the patient journey with a genomic window into the future

Helps guide treatment for prostate cancer

Learn More

Identifies subtypes of muscle-invasive bladder cancer

Learn More

Genomic intelligence for cancer discovery and research

Learn More

Genomics can reveal the true nature of a patient’s tumor

While clinical information such as stage and pathology are important in evaluating cancer, the unique genomic blueprint of a patient’s tumor is essential in optimizing treatment.

Be confident in treatment decisions

When Decipher is used in formulating a treatment plan, physicians and patients feel more confident that they are making the right decision.

Decipher is standard of care

Decipher testing is covered by Medicare and recommended by clinical practice guidelines for the management of prostate cancer.

Dedicated to improving patient care

Decipher Biosciences is reimagining the use of genomic information to transform and improve cancer patient care.

We are committed to delivering the most accurate tests for determining the true nature of prostate and bladder cancers, enabling each patient to have a treatment plan based on the unique biology of their tumor.